Approval · Notice of Compliance 11277 · 2010
AA-MEGESTROL: Notice of Compliance 11277
Issued April 22, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11277
- Date
- April 22, 2010
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Progestogen / Antineoplastic / Antianorexic / Anticachectic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AA-MEGESTROL | 02349213 | — |
| AA-MEGESTROL | 02349221 | — |
Medicinal ingredients
- MEGESTROL ACETATE 40 MG per TAB
- MEGESTROL ACETATE 160 MG per TAB